GrantExec

Foundation For Angelman Syndrome Therapeutics

EIN: 263160079
Accepts Applications
Total Assets
$58.4M
Key Financial Metrics (2024)

Total Giving

$5.6M

Number of Grants

17

Median Grant

$179K

Grant Range

$29K - $1.9M

Recent Grant Recipients

TEXAS A&M UNIVERSITY

FT2019-008: TRANSLATIONAL RESEARCH IN PIG MODEL OF AS

β€’ 2023

$267K

DUKE UNIVERSITY

FT2018-005 AMENDED: GPIC-COMM

β€’ 2023

$75K

YALE UNIVERSITY

FT2020-006: GENERATION AND CHARACTERIZATION OF A NEW AS MOUSE MODEL THAT RECAPITULATES THE LARGE DELETION OF HUMAN 15Q11-Q13 AND A CONTROL LINE THAT CARRIES A DELETION OF ALL GENES IN 15Q11-Q13 BUT UBE3A

β€’ 2023

$257K

YALE UNIVERSITY

PD2022-001: POSTDOCTORAL FELLOWSHIP PROGRAM

β€’ 2023

$51K

UNIVERSITY OF PENNSYLVANIA

UPENN 2023: RESEARCH, COLLABORATION & LICENSE AGREEMENT

β€’ 2023

$1.9M

NORTH CAROLINA STATE UNIVERSITY

FT2021-002: ISOGENICALLY CONTROLLED HUMAN CELL LINES TARGETING ABERRANT IMPRINTING GENOTYPES AND A NEW REPORTER CELL LINE.

β€’ 2023

$162K

NORTH CAROLINA STATE UNIVERSITY

FT2022-001: MICROPROBE-INTEGRATED HUMAN ORGANOID ARRAYS TO STUDY AS GENOTYPES AND THERAPEUTICS

β€’ 2023

$179K

NORTH CAROLINA STATE UNIVERSITY

FT2022-008: STEM CELL LINE IN-VITRO INFRASTRUCTURE CREATED AT NCSU FOR INDUSTRY AND ACADEMIC SUPPORT

β€’ 2023

$43K

NORTH CAROLINA STATE UNIVERSITY

RADAR 2023-2137

β€’ 2023

$29K

KECK GRADUATE INSTITUTE OF APPLIED LIFE SCIENCES

FT2022-002: TARGETING ANGELMAN SYNDROME THERAPEUTICS TO THE BRAIN UTILIZING NOVEL CELL PENETRATING PEPTIDES

β€’ 2023

$250K

Quick Facts

Location

Texas

Return Type

990

Most Recent Filing

2024

Annual Expenses

$23.2M

Giving Rate

9.5% of assets

Application Policy

Accepts Applications

Yes - Open to Applications